Efficacy of therapy of moderate ulcerative colitis MMX mesalazine
- 作者: Knyazev O.V.1, Belyakov N.I.1, Kagramanova A.V.1, Fadeeva N.A.1, Parfenov A.I.1
-
隶属关系:
- Moscow clinical scientific practical center
- 期: 编号 1 (2017)
- 页面: 150-158
- 栏目: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/277698
- ID: 277698
如何引用文章
详细
全文:
作者简介
Oleg Knyazev
Moscow clinical scientific practical center
Email: o.knyazev@mknc.ru
MD, head of the Department of inflammatory bowel diseases
Nikita Belyakov
Moscow clinical scientific practical centerresident physician
Anna Kagramanova
Moscow clinical scientific practical centerPhD, senior researcher, Department of inflammatory bowel diseases
Nina Fadeeva
Moscow clinical scientific practical centerPhD, senior researcher, Department of inflammatory bowel diseases
Askold Parfenov
Moscow clinical scientific practical centerMD, professor
参考
- Рекомендации по диагностике и лечению взрослых больных язвенным колитом. Колопроктология. 2013;3(45):4-38. [Guidelines for the diagnosis and treatment of ulcerative colitis in adults. Coloproctology. 2013;3(45):4-38 (in Russ.)]
- Першко А.М., Самедов Б.Х., Рукшина О.А. Неспецифический язвенный колит: диагностика и лечение. СПб., 2003. 112 с. [Pershko A.M., Samedov B.Kh., Rukshina O.A. Ulcerative colitis: diagnosis and treatment. SPb., 2003. 112 p. (in Russ.)]
- Sadler R.S. Epidemiology of inflammatory bowel disease. Inflammatory bowel disease: from bench to bedside. Baltimore, Williams and Wilkins, 1994:5-30.
- M'Koma A.E. inflammatory bowel disease: an expanding global health problem. Clinical medicine insights: gastroenterology. 2013;6:33-47.
- Белоусова Е.А., Никитина Н.В., Цодикова О.М. Лечение язвенного колита легкого и среднетяжелого течения. Фарматека. 2013;2:42-6. [Belousova Ye.A., Nikitina N.V., Tsodikova O.M. Treatment of ulcerative colitis of mild to moderate currents. Pharmateca. 2013;2:42-6 (in Russ.)]
- Халиф И.Л. Лечебная тактика при язвенном колите. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2006;16(3):58-62. [Khalif I.L. Therapeutic strategy for ulcerative colitis. Russ. J. Gastroenterol. Hepatol. Coloproctol. 2006;16(3):58-62 (in Russ.)]
- Халиф И.Л. Принципы лечения язвенного колита (рекомендации российской группы по изучению воспалительных заболеваний кишечника). Колопроктология. 2006;2:31-3. [Khalif I.L. Principles of treatment of ulcerative colitis (recommendations of the Russian group for the study of inflammatory bowel disease). Coloproctology. 2006;2:31-3 (in Russ.)]
- Dignass A., Lindsay J.O., Sturm A. et al. 2nd European evidence-based consensus on the diagnosis and management of ulcerative colitis. Part 2: Current management Journal of Crohn's and Colitis. 2012;6:991-1030.
- Langholz E., Munkholm P., Davidsen M., Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology. 1994;107:3-11.
- Michelassi F., Fichera A., Kirshner J.B. Inflammatory bowel disease. 5th ed. Philadelphia, 2000:616-26.
- Воробьев Г.И., Халиф И.Л. Неспецифические воспалительные заболевания кишечника. М.: Миклош, 2008. 400 c. [Vorob'ev G.I., Khalif I.L. Non-specific inflammatory bowel disease. Moscow: Miklosh, 2008. 400 p. (in Russ.)]
- Князев О.В., Чурикова А.А. Антицитокиновая терапия и качество жизни больных воспалительными заболеваниями кишечника. Доказательная гастроэнтерология. 2014;2:17-23. [Knyazev O.V., Churikova A.A. Anticytokine therapy and quality of life in patients with inflammatory bowel disease. Evidence-based gastroenterology. 2014;2:17-23 (in Russ.)]
- Travis S.P., Stange E.F., Lemann M., Oresland T., Bemelman W.A., Chowers Y., Colombel J.F., D'Haens G., Ghosh S., Marteau P., Kruis W., Mortensen N.J., Penninckx F., Gassull M. European evidence-based consensus on the management of ulcerative colitis: current management. J. Crohns. Colitis. 2008;2:24-62.
- Ford A.C., Achkar J.P., Khan K.J., Kane SV, Talley NJ, Marshall JK, Moayyedi P. Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis. Am. J. Gastroenterol. 2011;106:601-16.
- Ham M., Moss A.C. Mesalamine in the treatment and maintenance of remission of ulcerative colitis. Expert Rev. Clin. Pharmacol. 2012;5:113-23.
- Egan L.J., Sandborn W.J. Clinical pharmacology in inflammatory bowel disease: optimizing current medical therapy. In 2nd ed. London: Kluwer Academic publishers, 2002:495-522.
- D'Incà R., Paccagnella M., Cardin R., Pathak S., Baldo V., Giron M.C., Sturniolo G.C. 5-ASA colonic mucosal concentrations resulting from different pharmaceutical formulations in ulcerative colitis. World J. Gastroenterol. 2013;19(34):5665-70.
- Tenjarla S., Abinusawa A. In-vitro characterization of 5-aminosalicylic acid release from MMX mesalamine tablets and determination of tablet coating thickness. Adv. Ther. 2011;28:62-72.
- Tenjarla S., Romasanta V., Zeijdner E., Villa R., Moro L. Release of 5-aminosalicylate from an MMX mesalamine tablet during transit through a simulated gastrointestinal tract system. Adv. Ther. 2007;24:826-40.
- Brunner M., Assandri R., Kletter K., Tschurlovits M., Corrado M.E., Villa R., Eichler H.G., Müller M. Gastrointestinal transit and 5-ASA release from a new mesalazine extended-release formulation. Aliment Pharmacol. Ther. 2003;17:395-402.
- LachaineJ., Yen L., Beauchemin C., Hodgkins P. Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients:analyses with the RAMQ database. BMC Gastroenterology. 2013;13:23.
- Kane S., Huo D., Aikens J., Hanauer S. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am. J. Med. 2003;114(1):39-43.
- Kamm M.A., Lichtenstein G.R., Sandborn W.J., Schreiber S., Lees K., Barrett K., Joseph R. Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis. Gut. 2008;57:893-902.
- D'Haens G., Sandborn W.J., Feagan B.G., Geboes K., Hanauer S.B., Irvine E.J., Lémann M., Marteau P., Rutgeerts P., Schölmerich J., Sutherland L.R. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology. 2007;132(2):763-86.
- Schroeder K.W., Tremaine W.J., Ilstrup D.M. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N. Engl. J. Med. 1987;317(26):1625-9.
- Travis S.P.L., Stange E.F., Lemann M., Oresland T., Bemelman W.A., Chowers Y., Colombel J.F., D'Haens G., Ghosh S., Marteau P., Kruis W., Mortensen N.J., Penninckx F., Gassull M. European evidence-based consensus on the management of ulcerative colitis: current management. J. Crohn. Colitis. 2008;2:24-62.